Skip to main content
Premium Trial:

Request an Annual Quote

Personal Genome Diagnostics' CancerSelect Enterprise Solution

Personal Genome Diagnostics has launched its CancerSelect Enterprise Solution for labs with next-generation sequencing capabilities that aim to conduct advanced cancer genetic testing for research applications.  CancerSelect ES provides a turnkey solution that includes the firm's CancerSelect gene panels, proprietary bioinformatics software, staff training, ongoing technical support, report generation, and panel updates. The two PGDx CancerSelect panels detect alterations in 88 and 203 well-characterized genes that are of high biologic importance in cancer, and were selected for their relevance to cancer-related drug targets and pathways, according to the company.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.